Product Images Potassium-cit

These are Potassium citrate extended-release tablets used for the prevention of kidney stones. Each tablet has 10 mEq of potassium citrate, with tan to yellowish speckled color, and an elliptical shape. The recommended dosage should be read on the package insert. The tablets should be stored in a cool and dry place in a tight container at 20-25°C (68-77°F). The package is child-resistant, and pharmacists should dispense it in the original package without repackaging. This drug is distributed by Eywa Pharma Inc. in Princeton, NJ.*

NDC 71930-050-12 is a bottle of 100 tan to yellowish speckled, modified rectangle shaped, uncoated, extended-release tablets of Potassium Citrate USP. Each tablet contains 15 mEq (1,620 mg) of potassium citrate and is debossed with E36 on one side and plain on the other side. It is recommended to store this medication at 20° to 25°C (68° to 77°F) in a tight container and out of the reach of children. The package is child-resistant and pharmacists are advised to dispense the unit of use package without repackaging along with the package insert. The usual dosage is available on the package insert, which should be read before use.*

Potassium Citrate Extended-Release Tablets, USP with a strength of 5 mEq (540 mg) per tablet, comes in a pack of 100 tablets. Each tablet is uncoated, round, and speckled in tan to yellowish color. The product needs to be stored between 20°C to 25°C (68°F to 77°F) and in a child-resistant container. The package comes with a pharmacists' insert, which should be dispensed while giving this medication. The usual dosage can be found in the package insert.*